Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10
I agree with Drs Szarewski and Mansour that this study is concerning. These results will be picked up by commissioners and prescribing advisors who will then make decisions about restricting the use of these highly effective, popular contraceptives based on a poor evidence base.
We have done well nationally with reductions in teen pregnancy and abortions over the past few years. Good open access to a range of options has allowed women to make an informed choice of contraceptive method. By having a choice they are more likely to comply with the requirements of their chosen method which maximises efficacy and reduces the numbers of unplanned and unwanted pregnancy.
The report a few weeks ago by the Advisory Group on Contraception http://cleregolfserver.co.uk/bayer/sex-lives-and-commissioning/index.html clearly identified that there is a higher abortion rate in areas where limited access or prescribing restrictions are in place.
If commissioners and prescribing advisors make knee-jerk decisions based on poor studies such as this one we will be reduced to providing a range of cheaper, older, less well tolerated options to women and we are likely to see unplanned pregnancy rates increasing again.
Competing interests: Received honoraria, consultancy fees and conference sponsorship from Bayer Schering and MSD